Artificial Intelligence Applications in Lymphoma Diagnosis and Management: Opportunities, Challenges, and Future Directions
Miao Shen,Zhinong Jiang
DOI: https://doi.org/10.2147/jmdh.s485724
2024-11-27
Journal of Multidisciplinary Healthcare
Abstract:Miao Shen, 1, 2 Zhinong Jiang 1 1 Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310000, People's Republic of China; 2 Department of Pathology, Deqing People's Hospital, Huzhou City, Zhejiang Province, 313200, People's Republic of China Correspondence: Zhinong Jiang, Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No. 3 Qingchun East Road, Shangcheng District, Hangzhou City, Zhejiang Province, 310000, People's Republic of China, Tel +86 15105729672, Email Lymphoma, a heterogeneous group of blood cancers, presents significant diagnostic and therapeutic challenges due to its complex subtypes and variable clinical outcomes. Artificial intelligence (AI) has emerged as a promising tool to enhance the accuracy and efficiency of lymphoma pathology. This review explores the potential of AI in lymphoma diagnosis, classification, prognosis prediction, and treatment planning, as well as addressing the challenges and future directions in this rapidly evolving field. Keywords: artificial intelligence, machine learning, deep learning, lymphoma, digital pathology Lymphoma, a heterogeneous group of blood cancers, presents significant diagnostic and therapeutic challenges due to its complex subtypes and variable clinical outcomes. 1 Accurate diagnosis and classification of lymphoma are critical for determining appropriate treatment strategies and predicting patient prognosis. 2 However, traditional diagnostic methods, such as histopathological examination, immunohistochemistry, and molecular testing, can be time-consuming, labour-intensive, and subject to inter-observer variability. 3 Artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), has emerged as a promising tool to enhance the accuracy, efficiency, and reproducibility of lymphoma diagnosis and management. 4 Lymphoma is a diverse group of malignancies originating from lymphocytes, with multiple subtypes characterised by distinct histological, immunophenotypic, and molecular features. 5 The World Health Organization (WHO) classification system for lymphoid neoplasms recognises over 90 distinct entities, each with unique clinical presentations, therapeutic implications, and prognostic outcomes. 6 Accurate diagnosis and classification of lymphoma are crucial for determining appropriate treatment strategies and predicting patient survival. 7 However, the increasing complexity of lymphoma classification poses challenges for pathologists and can lead to discrepancies in diagnosis and suboptimal patient management. 8 Traditional diagnostic methods for lymphoma rely on histopathological examination of tissue biopsies, immunohistochemical staining for specific markers, and molecular testing for genetic aberrations. 9 As noted, these methods require extensive manual labour and specialised expertise, and are subject to inter-observer variability. 10 Moreover, the interpretation of histopathological features and immunohistochemical patterns can be challenging, especially in cases with atypical morphology or overlapping features between different lymphoma subtypes. 11 Artificial intelligence, especially ML and DL, has demonstrated remarkable potential in various domains of pathology, including cancer diagnosis, prognosis prediction, and treatment response assessment. 12 Machine learning algorithms can learn from large datasets and extract meaningful patterns and relationships, enabling automated and objective analysis of complex medical data. 13 As a subfield of ML, DL utilises artificial neural networks with multiple layers to learn hierarchical representations of data, allowing for more accurate and efficient feature extraction and classification. 14 The application of AI in lymphoma pathology has gained significant attention in recent years, with numerous studies demonstrating its potential to improve diagnostic accuracy, streamline workflows, and provide novel insights into disease biology. 15 Artificial intelligence algorithms can analyse various types of data, including histopathological images, immunohistochemical stains, molecular profiles, and clinical variables, to assist in lymphoma diagnosis, classification, prognosis prediction, and treatment planning. 16 This comprehensive review explores the current state-of-the-art applications of AI in lymphoma pathology, highlighting the opportunities, challenges, and future directions in this rapidly evolving field. The review discusses the use of AI in lymphoma detection and diagnosis, classification, prognosis prediction, treatment planning, and integration -Abstract Truncated-
health care sciences & services